Blog

  • The Longoza NMN that May Protect Against COVID-19
    Post time: 11-09-2021

    As researchers scramble to understand COVID-19, a question remains; Why are elderly at such an increased risk of perishing from this disease?  It may seem obvious given that older adults tend to have weaker immune systems, but historically, infectious diseases don’t alwa...Read more »

  • Longoza NMN: Benefits, Side Effects & Dosage
    Post time: 11-09-2021

    Thanks to modern medicine and advances in public health, the world’s population is living longer. The number of people aged over 80 will triple in the next 30 years, according to the projections of World Population Prospects 2019 from the United Nations’ Department of Ec...Read more »

  • Can Longoza NMN cure cancer?
    Post time: 11-09-2021

    All cells need nicotinamide adenine dinucleotide (NAD+), a bioenergetic molecule, to carry out essential functions and for survival. But NAD+ (THE RESULT OF LONGOZA NMN GETS INTO HUMAN BODY) production (biosynthesis) is often elevated in human cancers, where it plays a c...Read more »

  • Post time: 04-16-2020

    The sirtuins (SIRT1–7) are a family of nicotinamide adenine dinucleotide (NAD+)-dependent deacylases with remarkable abilities to prevent diseases and even reverse aspects of ageing. Mice engineered to express additional copies of SIRT1 or SIRT6, or treated with sirtuin-activating compounds (STAC...Read more »

  • Post time: 03-16-2020

    The mammalian sirtuins (SIRT1–7) are NAD+-dependent lysine deacylases that play central roles in cell survival, inflammation, energy metabolism, and aging. Members of this family of enzymes are considered promising pharmaceutical targets for the treatment of age-related diseases including cancer,...Read more »

  • Post time: 02-16-2020

    Boosting nicotinamide adenine dinucleotide (NAD+) improves health in a clinical study Nicotinamide adenine dinucleotide (NAD+) is an essential metabolic co- factor that is central to energy me- tabolism. During aging, obesity, and diabetes, NAD+ concentrations in cells decline. NAD is synthesized...Read more »

  • Post time: 01-16-2020

    In rodents, obesity and aging impair nicotinamide adenine dinucleotide (NAD+) biosynthesis, which contributes to metabolic dysfunction. Nicotinamide mononucleotide (NMN) availability is a rate-limiting factor in mammalian NAD+ biosynthesis. We conducted a 10-week, randomized, placebo-controlled, ...Read more »